Zeocin
To Order Contact us: stephen@expresspharmapulse.com
pCDNA3.1- Zeo- GPR35- r |
|||
| PVT11638 | Lifescience Market | 2 ug | EUR 364.8 |
pCDNA3.1 (+)- Zeo Plasmid |
|||
| PVT1005 | Lifescience Market | 2 ug | EUR 319.2 |
pDONR221/ Zeo Plasmid |
|||
| PVT3101 | Lifescience Market | 2 ug | EUR 289.2 |
lenti sgRNA (MS2)_zeo backbone |
|||
| PVT11344 | Lifescience Market | 2 ug | EUR 361.2 |
CMV control lentivirus (Zeo) |
|||
| CMV-Null-Zeo | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter. |
|||
EF1a control lentivirus (Zeo) |
|||
| EF1a-Null-Zeo | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter. |
|||